Effects of Altered Glucose Utilization on AB Levels and Functional Connectivity
Effects of Altered Glucose Utilization on AB Levels and Functional Connectivity
批准号:
8636916
负责人:
Shannon L Macauley-Rambach
金额:
$5.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2016-03-31
关键词:
APP-PS1AccountingAcuteAffectAgeAgonistAlzheimer&aposs DiseaseAmericanAmyloidAmyloid beta-ProteinBilateralBiochemicalBlood GlucoseBrainBrain regionCerebrumCharacteristicsChronicClinicalDataDementiaDepositionDevelopmentDiabetes MellitusDiazoxideDisease ProgressionElderlyElectroencephalographyEpidemiologic StudiesEuglycemic ClampingGenerationsGeneticGlucoseGlucose ClampGoalsHealth Care CostsHippocampus (Brain)HyperglycemiaImageImpaired cognitionInsulinInsulin ResistanceIntercellular FluidLinkLong-Term EffectsMediatingMembrane PotentialsMetabolic DiseasesMetabolismMicrodialysisModelingMonitorMusNeuronsNon-Insulin-Dependent Diabetes MellitusOpticsOxygen ConsumptionPathogenesisPathologyPatientsPeptidesPositron-Emission TomographyPotassiumProductionRelative (related person)ResearchRiskRoleSenile PlaquesSignal TransductionSymptomsTimeWorkagedamyloid precursor protein processingextracellularglucose metabolismglucose uptakein vivoin vivo imaginginterstitialmouse modelneurochemistryneuronal excitabilitynovelpeptide Apublic health relevancerelating to nervous systemtau Proteins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common form of dementia, affecting approximately 30 million people worldwide. Accumulation of the amyloid-¿ (A¿) peptide in the brain is hypothesized to be a key instigator in the pathogenesis of Alzheimer's disease (AD). Approximately 10-15 years prior to cognitive decline, aggregation of normally soluble monomeric A¿ accumulates into toxic forms, most notably amyloid plaques, within specific brain regions in the AD brain. Recent studies identified characteristics common to these AD prone regions including high neuronal activity, high functional connectivity, and high glucose utilization (relative to oxygen consumption). Interestingly, one of the first changes observed in the AD brain prior to or concurrent with clinical symptoms is aberrant glucose uptake. Furthermore, recent epidemiological studies suggest that patients with diabetes, a metabolic disorder characterized by chronic hyperglycemia, have a 2-4 increased risk for developing AD. Taken together, these observations implicate alterations in glucose metabolism in the disease progression of AD. Preliminary data suggests that a systemic increase in blood glucose levels results in a significant increase in A¿ production within the brain's interstitial fuid (ISF). Therefore, the goal of this proposal is to properly understand the relationship between aberrant glucose metabolism, neuronal activity, and functional connectivity as it relates to A¿ production and deposition in a mouse model of AD. By combining glucose clamps, to alter systemic blood glucose levels, with in vivo microdialysis, to ascertain the effects of systemic glucose modulation on the brain's neurochemistry, a direct understanding of how changes in blood glucose levels affect A¿ production and deposition, both acutely and chronically, can be achieved. Similarly, by monitoring neuronal activity via EEG recordings and functional connectivity via functional connectivity optical instrinsic signaling imaging (fcOIS), a better understanding of how increases in blood glucose levels and ISF A¿ affect these variables will be attained. Lastly, this proposal also seeks to identify the underlying mechanisms that cause alterations in blood glucose levels to result in increased A¿ levels. Thus, this proposal will help
elucidate the role of glucose metabolism in AD pathogenesis as well as the link between AD and diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The metabolic interplay of sleep and Alzheimer's disease
-
批准号:10611889
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2020
-
负责人:Shannon L Macauley-Rambach
-
依托单位:
The metabolic interplay of sleep and Alzheimer's disease
-
批准号:10221598
-
项目类别:
-
资助金额:$70.6万
-
财政年份:2020
-
负责人:Shannon L Macauley-Rambach
-
依托单位:
The metabolic interplay of sleep and Alzheimer's disease
-
批准号:10030868
-
项目类别:
-
资助金额:$67.06万
-
财政年份:2020
-
负责人:Shannon L Macauley-Rambach
-
依托单位:
The metabolic interplay of sleep and Alzheimer's disease
-
批准号:10398178
-
项目类别:
-
资助金额:$70.6万
-
财政年份:2020
-
负责人:Shannon L Macauley-Rambach
-
依托单位:
Effects of Hyperglycemia on Neuronal Activity, Cerebral Metabolism, and Amyloid-beta Levels
-
批准号:9905321
-
项目类别:
-
资助金额:$11.45万
-
财政年份:2016
-
负责人:Shannon L Macauley-Rambach
-
依托单位:
Effects of Altered Glucose Utilization on AB Levels and Functional Connectivity
-
批准号:8524085
-
项目类别:
-
资助金额:$5.39万
-
财政年份:2013
-
负责人:Shannon L Macauley-Rambach
-
依托单位:
Cellular Pathology of Batten Disease
-
批准号:7275767
-
项目类别:
-
资助金额:$2.78万
-
财政年份:2007
-
负责人:Shannon L Macauley-Rambach
-
依托单位:
Cellular Pathology of Batten Disease
-
批准号:7414100
-
项目类别:
-
资助金额:$2.81万
-
财政年份:2007
-
负责人:Shannon L Macauley-Rambach
-
依托单位:
Cellular Pathology of Batten Disease
-
批准号:7610985
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2007
-
负责人:Shannon L Macauley-Rambach
-
依托单位:
海外基金